• OPEN AN ACCOUNT
Indian Indices
Nifty
25,910.05 -103.40
(-0.40%)
Sensex
84,673.02 0.00
( 0.00%)
Bank Nifty
58,899.25 -63.45
( -0.11%)
Nifty IT
35,975.20 -400.00
( -1.10%)
Global Indices
Nasdaq
46,120.46 -490.79
(-1.05%)
Dow Jones
6,640.03 -53.38
(-0.80%)
Hang Seng
48,833.62 -1,490.29
(-2.96%)
Nikkei 225
9,519.69 -155.74
(-1.61%)
Forex
USD-INR
88.63 -0.03
(-0.03%)
EUR-INR
102.78 -0.24
(-0.23%)
GBP-INR
116.64 -0.09
(-0.08%)
JPY-INR
0.57 0.00
(-0.26%)

EQUITY - MARKET SCREENER

Welcure Drugs & Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524661
INE331C01025
1.0860857
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
2
69.21
EPS(TTM)
Face Value()
Div & Yield %
0.28
1
0
 

modern engineering & projects limited
Josts Engineering slips after weak Q2 performance
Nov 03,2025
On a standalone basis, the company’s net profit slumped 70% year-on-year (YoY) to Rs 1.23 crore on a 19.2% decline in net sales to Rs 47.36 crore in Q2 FY26 over Q2 FY25. Profit before tax dropped 66.96% YoY to Rs 1.88 crore but jumped 108.89% sequentially.

Total expenses fell 13.7% YoY to Rs 45.88 crore during the quarter. Employee benefit expenses declined 16.6% YoY to Rs 5.04 crore, while finance costs increased 17.7% YoY to Rs 0.73 crore.

Mumbai-based Jost’s Engineering Company is engaged in manufacturing and supplying material handling equipment (MHE) and engineering product (EPD) solutions catering to various industries.